6 Jul 2012 10:37
AIM: ODX
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company)
Director Dealing
Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Andrew Shepherd, Chief Executive, today purchased 62,500 shares at 16p per share. Following this share purchase, Mr Shepherd now has an interest in 2,018,030 shares representing approximately 2.37 per cent. of the issued share capital of the Company.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
Seymour Pierce Group | Tel: 020 7107 8000 www.seymourpierce.com |
Freddy Crossley / Mark Percy (Corporate Finance) David Banks / Katie Ratner (Corporate Broking) | |
Walbrook PR Limited | |
Paul McManus | Tel: 020 7933 8787 Mob: 07980 541 893 paul.mcmanus@walbrookpr.com
|
Paul Cornelius | Tel: 020 7933 8794 |
Mob: 07886 384 707 | |
paul.cornelius@walbrookpr.com |
ODX.L (ODX)